DOES HIV COINFECTION AFFECT THE OUTCOME OF ANTITUBERCULOSIS TREATMENT?
##plugins.themes.bootstrap3.article.sidebar##
##plugins.themes.bootstrap3.article.main##
Abstract
Background: Tuberculosis (TB) is a major problem in developing countries, including Indonesia. One of the most important risk factors for developing active TB is HIV coinfection. Thus, HIV increases global burden of TB and TB is one of the leading causes of death among people with HIV. HIV patients have up to 20 times higher risk of developing active TB compared to those without HIV infection. Treatment and management of tuberculosis in HIV patients are challenging, mostly due to inadequate diagnostics and treatment.
Method: The study was conducted in 2014 using a retrospective case-control method (unsuccess TB treatment patients as case group; successful TB as control group) with purposive sampling technique. Demographic data, TB treatment, and outcome therapy were documented and analyzed to determine factors affecting successful TB treatment in HIV/TB coinfection patients. Statistical analysis was performed using univariate and multivariate logistic regression model.
Objectives: This study was aimed to analyze the outcomes of the TB treatment in HIV/TB coinfection in Bandung and the affecting factors.
Result: 531 patients (85 cases; 446 controls) were involved in this study. Demographic data showed that 7,7% of patients were HIV/TB coinfection patients and most patients (78,05%) received category 1 of antituberculosis drugs. HIV coinfection independently affected the success of TB treatment. The successful rate of TB treatment in Bandung was 83,9%. TB patients with HIV positive tended to be 2,740 times less likely to succeed in TB treatment compared to TB patients with HIV negative [OR=2,740; 95% CI (1.051-7.140), p=0.039*]. Factors affecting the successful outcome of TB treatment is gender (woman>man, p<0,05), location/access to medication (p<0,05), and the AFB-negative conversion during intensive phase of treatment (p<0,01).
Conclusion: HIV coinfection lower the successful rate of TB treatment with odds ratio 2,740. Factors affecting the successful rate of TB treatment are gender, access to medication, and AFB conversion during intensive phase of treatment.
Keywords: HIV/TB coinfection; treatment outcomes, factors.
##plugins.themes.bootstrap3.article.details##
References
Avihingsanon, A., Hemachandra, A. and van de Lugt, J. (2009) Antiretroviral Therapy for HIV-Associated Tuberculosis. Asian Biomedicine, 3, 73-87.
Ayed HB, Koubaa M, Marrakchi C, Rekik K, Hammami F, et al. (2018) Extrapulmonary Tuberculosis: Update on the Epidemiology, Risk Factors and Prevention Strategies. Int J Trop Dis 1:006. doi.org/10.23937/ijtd-2017/1710006
Babalik, A., Kiziltas, S., Arda, H., Oruc, K., Cetintas, G., Calisir, H.C., 2012. Factors affecting smear conversion in tuberculosis management, Medicine Science 2012;1(4):351-62.
Bell LCK, Noursadeghi M. Pathogenesis of HIV-1 and Mycobacterium tuberculosis co-infection. Nat Rev Microbiol. 2018 Feb;16(2):80-90. doi: 10.1038/nrmicro.2017.128. Epub 2017 Nov 7. PMID: 29109555.
Boateng, S.A., Kodama, T., Tachibana, T. and Hyoi, N. (2010) Factors Contributing to Tuberculosis (TB) Defaulter Rate in New Juaben Municipality in the Eastern Region of Ghana. Journal of the National Institute of Public Health, 59, 291-297.
Chaves Torres NM, Quijano Rodrı´guez JJ, Porras Andrade PS, Arriaga MB, Netto EM (2019) Factors predictive of the success of tuberculosis treatment: A systematic review with meta-analysis. PLoS ONE 14(12): e0226507. https://doi.org/10.1371/journal.pone.0226507.
Fibriana, A,I., Saefurrohim, M.Z., Setiana, A.A., Azamm, M., Pratama, A.D., 2020, Predictors of smear non-conversion among new-treatment pulmonary tuberculosis: a single center case-control study in Indonesia. Medical Journal of Indonesia. 2020;29:410–6.
G.S. Smith, S.K. Van Den Eeden, R. Baxter, J. Shan, A. Van Rie, A.H. Herring, et al. Cigarette smoking and pulmonary tuberculosis in northern California. J Epidemiol Community Health, 69 (2015), pp. 568-573
Gebre, M., Kebede, M., 2009. Adherence to treatment of tuberculosis in patients with TB/HIV co-infection on concomitant treatment in Addis-Abeba, Ethiopia. Master Thesis. Oslo: University of Oslo.
Kadima JN, Mukanyangezi MF, Uwizeye CB. Effectiveness and safety of concurrent use of first-line antiretroviral and antituberculous drugs in rwanda. J Trop Med. 2014;2014:904957. doi: 10.1155/2014/904957. Epub 2014 Jan 30. PMID: 24624142; PMCID: PMC3929278.
Kayigamba FR, Bakker MI, Mugisha V, De Naeyer L, Gasana M, Cobelens F, van der Loeff MS. Adherence to tuberculosis treatment, sputum smear conversion and mortality: a retrospective cohort study in 48 Rwandan clinics. PLoS One. 2013 Sep 16;8(9):e73501. doi: 10.1371/journal.pone.0073501. PMID: 24066053; PMCID: PMC3774710.
Lawn SD, Harries AD, Williams BG, Chaisson RE, Losina E, De Cock KM, Wood R. Antiretroviral therapy and the control of HIV-associated tuberculosis. Will ART do it? Int J Tuberc Lung Dis. 2011 May;15(5):571-81. doi: 10.5588/ijtld.10.0483. PMID: 21756508; PMCID: PMC4067901.
Manosuthi, W., Wiboonchutikul, S., Sungkanuparph, S. 2016. Integrated therapy for HIV and tuberculosis. AIDS Res Ther (2016) 13:22.
Marahatta SB, Yadav RK, Giri D, Lama S, Rijal KR, et al. (2020) Barriers in the access, diagnosis and treatment completion for tuberculosis patients in central and western Nepal: A qualitative study among patients, community members and health care workers. PLOS ONE 15(1): e0227293. https://doi.org/10.1371/journal.pone.0227293
Marçôa, R., Ribeiro, A.I., Zão, I., Duarte, R., 2018. Tuberculosis and gender, Factors influencing the risk of tuberculosis among men and women by age group. J Epidemiol Community Health, 24 (2018), pp. 199-202.
Marks DJ, Dheda K, Dawson R, Ainslie G, Miller RF. Adverse events to antituberculosis therapy: influence of HIV and antiretroviral drugs. Int J STD AIDS. 2009 May;20(5):339-45. doi: 10.1258/ijsa.2008.008361. PMID: 19386972.
Michael OS, Sogaolu OM, Fehintola FA, Ige OM, Falade CO. ADVERSE EVENTS TO FIRST LINE ANTI-TUBERCULOSIS DRUGS IN PATIENTS CO-INFECTED WITH HIV AND TUBERCULOSIS. Ann Ib Postgrad Med. 2016 Jun;14(1):21-29. PMID: 27721682; PMCID: PMC5049598.
Muture BN, Keraka MN, Kimuu PK, Kabiru EW, Ombeka VO, Oguya F. Factors associated with default from treatment among tuberculosis patients in Nairobi province, Kenya: a case control study. BMC Public Health. 2011 Sep 9;11:696. doi: 10.1186/1471-2458-11-696. PMID: 21906291; PMCID: PMC3224095.
Resende NH, Miranda SS, Ceccato MDGB, Haddad JPA, Reis AMM, Silva DID, Carvalho WDS. Drug therapy problems for patients with tuberculosis and HIV/AIDS at a reference hospital. Einstein (Sao Paulo). 2019 Aug 22;17(4):eAO4696. doi: 10.31744/einstein_journal/2019AO4696. PMID: 31460617; PMCID: PMC6706227.
Sanchez M, Bartholomay P, Arakaki-Sanchez D, Enarson D, Bissell K, et al. (2012) Outcomes of TB Treatment by HIV Status in National Recording Systems in Brazil, 2003–2008. PLOS ONE 7(3): e33129. https://doi.org/10.1371/journal.pone.0033129
Shivakoti R, Sharma D, Mamoon G, Pham K. Association of HIV infection with extrapulmonary tuberculosis: a systematic review. Infection. 2017 Feb;45(1):11-21. doi: 10.1007/s15010-016-0960-5. Epub 2016 Nov 9. PMID: 27830524; PMCID: PMC5303538.
van de Water BJ, Fulcher I, Cilliers S, Meyer N, Wilson M, Young C, et al. (2022) Association of HIV infection and antiretroviral therapy with the occurrence of an unfavorable TB treatment outcome in a rural district hospital in Eastern Cape, South Africa: A retrospective cohort study. PLoS ONE 17(4): e0266082. https://doi.org/10.1371/journal.pone.0266082
WHO (2018). Management of Tuberculosis and HIV Coinfection : Critical Protocol for the WHO European Region. Geneva: World Health Organization; 2018.
WHO, 2007. Implementing the WHO Stop TB Strategy: A Handbook for National Tuberculosis Control Programmes. Available from https://www.ncbi.nlm.nih.gov/books/NBK310759/. Geneva: World Health Organization; 2008:2.
WHO, 2021. Global Tuberculosis Report, 2021. Geneva: World Health Organization.
Yusria, A., Rintiswati, N., Sumardi. (2017). Factors Associated with Tuberculosis Treatment Success Among Human Immunodeficiency Virus - Tuberkulosis (HIV-TB) in H. Adam Malik General Hospital, Medan. Tropical Medicine Journal. 4(01). Pp. 16-24.
Zachariah R, Fitzgerald M, Massaquoi M, Acabu A, Chilomo D, Salaniponi FM, Harries AD. Does antiretroviral treatment reduce case fatality among HIV-positive patients with tuberculosis in Malawi? Int J Tuberc Lung Dis. 2007 Aug;11(8):848-53. PMID: 17705949.